Tsun-Huei Lee
Vermögen: 62 280 $ am 31.07.2026
Vermögen: 62 280 $ am 31.07.2026
Tsun-Huei Lee is the founder of Translate Bio, Inc., founded in 2011, and Fulcrum Therapeutics, Inc., founded in 2015.
Current jobs include Independent Non-Executive Director at GSK Plc since 2024, Chair-Molecular Biology at The General Hospital Corp., Member of the National Academy of Sciences, and Member of the National Academy of Medicine (United States).
Former job includes Director at The Genetics Society of America.
Education history includes undergraduate studies at Harvard University and a doctorate from Perelman School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GSK PLC 0% | 10.07.2026 | 2’396 ( 0% ) | 62 280 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Direktor/Vorstandsmitglied | 04.03.2024 |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Gründer | - |
| TRANSLATE BIO, INC. | Gründer | - |
The Genetics Society of America
The Genetics Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for scientific researchers and educators in the field of genetics | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
The Genetics Society of America
The Genetics Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for scientific researchers and educators in the field of genetics | Commercial Services |
Perelman School of Medicine
Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen